首頁 > 市場調查報告書 > 製藥

糖尿病

市場調查報告書

商品編碼

1729515

日本糖尿病設備市場報告（按類型（管理設備、監測設備）、配銷通路（醫院藥房、零售藥房、糖尿病診所/中心、線上藥房等）和地區）2025 年至 2033 年

Japan Diabetes Devices Market Report by Type (Management Devices, Monitoring Devices), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics/Centers, Online Pharmacies, and Others), and Region 2025-2033

出版日期: 2025年05月01日 | 出版商:

IMARC | 英文 121 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2024 年，日本糖尿病設備市場規模達 19.36 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 24.87 億美元，2025-2033 年期間的成長率 (CAGR) 為 2.8%。重大創新和技術進步主要致力於滿足糖尿病管理、監測和治療的多方面需求，是推動市場成長的主要動力。

糖尿病設備是指專門設計用於管理、監測和治療糖尿病（一種以血糖升高為特徵的慢性疾病）的一類醫療設備。這些設備在幫助糖尿病患者維持最佳血糖水平和預防不受控制的糖尿病相關併發症方面發揮著重要作用。糖尿病設備包括血糖監測儀、胰島素幫浦、胰島素筆和持續血糖監測 (CGM) 系統等。血糖監測儀用於間歇性血糖測試，而後者提供全天的即時血糖讀數。胰島素幫浦和胰島素筆對於胰島素的輸送至關重要，胰島素是碳水化合物、脂肪和蛋白質代謝所必需的荷爾蒙。隨著技術的進步，這些設備變得更加方便用戶使用、準確和微創，可以滿足糖尿病患者的特定需求和偏好。應用程式和遠距醫療平台等數位技術的結合也有助於透過提供個人化護理和遠端監控功能來更好地管理糖尿病。從本質上講，糖尿病設備對於幫助糖尿病患者過上更健康、更容易管理的生活至關重要，可以促進醫療技術和醫療保健的進步。

日本糖尿病設備市場趨勢：

日本糖尿病設備市場正經歷一段大幅成長期，這受到人口老化和國內糖尿病盛行率上升等多種趨勢和促進因素的推動。由於日本擁有大量老年人口，對創新高效的糖尿病管理設備的需求比以往任何時候都更加重要，從而推動了該領域的進步和投資。人們的健康意識和糖尿病自我管理意識的增強導致對使用者友好、準確、技術先進的設備的需求增加，例如連續血糖監測系統和胰島素輸送設備。技術創新以及物聯網和人工智慧的整合是市場的重要趨勢，增強了糖尿病設備的功能，提供即時監控、資料分析和個人化建議，從而提高了糖尿病護理的標準。政府針對醫療創新和慢性病管理的支持政策和措施也起到了催化劑的作用，促進了市場的發展軌跡。此外，科技公司和醫療設備製造商之間的合作關係不斷加強，促進了更複雜解決方案的開發。醫療保健提供者和患者對這些先進糖尿病設備的接受度和採用度不斷提高，預計將進一步促進市場成長。對微創或非侵入性設備的重視以及遠距醫療和遠端監控的普及正在重塑日本糖尿病管理的格局，預示著該地區糖尿病設備市場前景光明。

日本糖尿病設備市場細分：

類型洞察：

管理設備
o胰島素幫浦
o胰島素注射器
可重複使用筆中的墨盒
o一次性胰島素筆
oJet 噴射器
監控設備
自我監測血糖
o持續血糖監測

配銷通路洞察：

醫院藥房
零售藥局
糖尿病診所/中心
網路藥局
其他

競爭格局：

市場研究報告也對競爭格局進行了全面的分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀表板和公司評估象限等競爭分析。此外，也提供了所有主要公司的詳細資料。一些關鍵參與者包括：

愛科來株式會社
Ascensia糖尿病照護控股公司
Dexcom公司
泰爾茂株式會社

本報告回答的關鍵問題：

日本糖尿病設備市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本糖尿病設備市場有何影響？
日本糖尿病設備市場依類型分為哪些類型？
依照配銷通路，日本糖尿病設備市場是如何分類的？
日本糖尿病設備市場的價值鏈分為哪些階段？
日本糖尿病設備的主要促進因素和挑戰是什麼？
日本糖尿病設備市場的結構是怎麼樣的？主要參與者是誰？
日本糖尿病設備市場的競爭程度如何？

本報告回答的關鍵問題：

日本糖尿病設備市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本糖尿病設備市場有何影響？
日本糖尿病設備市場依類型分為哪些類型？
依照配銷通路，日本糖尿病設備市場是如何分類的？
日本糖尿病設備市場的價值鏈分為哪些階段？
日本糖尿病設備的主要促進因素和挑戰是什麼？
日本糖尿病設備市場的結構是怎麼樣的？主要參與者是誰？
日本糖尿病設備市場的競爭程度如何？

Japan diabetes devices market size reached USD 1,936 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 2,487 Million by 2033, exhibiting a growth rate (CAGR) of 2.8% during 2025-2033. Significant innovations and technological advancements, focused on addressing the multifaceted demands of diabetic management, monitoring, and treatment are primarily driving the market growth.

Diabetes devices refer to a category of medical equipment specifically designed to manage, monitor, and treat diabetes, a chronic condition characterized by elevated blood sugar levels. These devices play an essential role in assisting individuals with diabetes to maintain optimal blood glucose levels and prevent complications associated with uncontrolled diabetes. Diabetes devices include blood glucose monitors, insulin pumps, insulin pens, and continuous glucose monitoring (CGM) systems, amongst others. Blood glucose monitors are utilized for intermittent blood sugar testing, while the latter provide real-time glucose readings throughout the day. Insulin pumps and pens are crucial for the delivery of insulin, a hormone essential for the metabolism of carbohydrates, fats, and proteins. These devices, with their advancements in technology, are becoming more user-friendly, accurate, and minimally invasive, catering to the specific needs and preferences of diabetic patients. The incorporation of digital technologies such as apps and telemedicine platforms also helps in better diabetes management by offering personalized care and remote monitoring capabilities. In essence, diabetes devices are pivotal in empowering individuals with diabetes to lead a healthier and more manageable life, fostering advancements in medical technology and healthcare.

Japan Diabetes Devices Market Trends:

The Japan diabetes devices market is witnessing a period of substantial growth, driven by a confluence of trends and drivers, including an aging population and increasing prevalence of diabetes within the country. With Japan being home to a considerable elderly demographic, the necessity for innovative and efficient diabetes management devices is more paramount than ever, propelling advancements and investments in this sector. The surge in health consciousness and self-management of diabetes is leading to increased demand for user-friendly, accurate, and technologically advanced devices, such as continuous glucose monitoring systems and insulin delivery devices. Technological innovations and the integration of IoT and AI are significant trends in the market, enhancing the functionalities of diabetes devices, offering real-time monitoring, data analysis, and personalized recommendations, thus elevating the standard of diabetes care. The government's supportive policies and initiatives aimed at healthcare innovation and chronic disease management also act as catalysts, bolstering the market's trajectory. Moreover, the rise in partnerships between tech companies and medical device manufacturers is fostering the development of more sophisticated solutions. The growing acceptance and adoption of these advanced diabetes devices among healthcare providers and patients are anticipated to further augment the market growth. The emphasis on minimally invasive or non-invasive devices and the proliferation of telehealth and remote monitoring are reshaping the landscape of diabetes management in Japan, indicating a promising future for the diabetes devices market in the region.

Japan Diabetes Devices Market Segmentation:

Type Insights:

Management Devices
oInsulin Pump
oInsulin Syringes
oCartridges in Reusable Pens
oInsulin Disposable Pens
oJet Injectors
Monitoring Devices
Self-monitoring Blood Glucose
oContinuous Glucose Monitoring

Distribution Channel Insights:

Hospital Pharmacies
Retail Pharmacies
Diabetes Clinics/Centers
Online Pharmacies
Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the key players include:

ARKRAY Inc.
Ascensia Diabetes Care Holdings AG
Dexcom Inc.
Terumo Corporation

Key Questions Answered in This Report:

How has the Japan diabetes devices market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan diabetes devices market?
What is the breakup of the Japan diabetes devices market on the basis of type?
What is the breakup of the Japan diabetes devices market on the basis of distribution channel?
What are the various stages in the value chain of the Japan diabetes devices market?
What are the key driving factors and challenges in the Japan diabetes devices?
What is the structure of the Japan diabetes devices market and who are the key players?
What is the degree of competition in the Japan diabetes devices market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Diabetes Devices Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Diabetes Devices Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Diabetes Devices Market - Breakup by Type

6.1 Management Devices
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Segmentation
  - 6.1.3.1 Insulin Pump
  - 6.1.3.2 Insulin Syringes
  - 6.1.3.3 Cartridges in Reusable Pens
  - 6.1.3.4 Insulin Disposable Pens
  - 6.1.3.5 Jet Injectors
- 6.1.4 Market Forecast (2025-2033)
6.2 Monitoring Devices
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Segmentation
  - 6.2.3.1 Self-monitoring Blood Glucose
  - 6.2.3.2 Continuous Glucose Monitoring
- 6.2.4 Market Forecast (2025-2033)

7 Japan Diabetes Devices Market - Breakup by Distribution Channel

7.1 Hospital Pharmacies
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Retail Pharmacies
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
7.3 Diabetes Clinics/Centers
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)
7.4 Online Pharmacies
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2019-2024)
- 7.4.3 Market Forecast (2025-2033)
7.5 Others
- 7.5.1 Historical and Current Market Trends (2019-2024)
- 7.5.2 Market Forecast (2025-2033)

8 Japan Diabetes Devices Market - Competitive Landscape

8.1 Overview
8.2 Market Structure
8.3 Market Player Positioning
8.4 Top Winning Strategies
8.5 Competitive Dashboard
8.6 Company Evaluation Quadrant

9 Profiles of Key Players

9.1 ARKRAY Inc.
- 9.1.1 Business Overview
- 9.1.2 Product Portfolio
- 9.1.3 Business Strategies
- 9.1.4 SWOT Analysis
- 9.1.5 Major News and Events
9.2 Ascensia Diabetes Care Holdings AG
- 9.2.1 Business Overview
- 9.2.2 Product Portfolio
- 9.2.3 Business Strategies
- 9.2.4 SWOT Analysis
- 9.2.5 Major News and Events
9.3 Dexcom Inc.
- 9.3.1 Business Overview
- 9.3.2 Product Portfolio
- 9.3.3 Business Strategies
- 9.3.4 SWOT Analysis
- 9.3.5 Major News and Events
9.4 Terumo Corporation
- 9.4.1 Business Overview
- 9.4.2 Product Portfolio
- 9.4.3 Business Strategies
- 9.4.4 SWOT Analysis
- 9.4.5 Major News and Events

10 Japan Diabetes Devices Market - Industry Analysis

10.1 Drivers, Restraints and Opportunities
- 10.1.1 Overview
- 10.1.2 Drivers
- 10.1.3 Restraints
- 10.1.4 Opportunities
10.2 Porters Five Forces Analysis
- 10.2.1 Overview
- 10.2.2 Bargaining Power of Buyers
- 10.2.3 Bargaining Power of Suppliers
- 10.2.4 Degree of Competition
- 10.2.5 Threat of New Entrants
- 10.2.6 Threat of Substitutes
10.3 Value Chain Analysis